ASCO 2021: Best Lung Cancer IO Data ASCO 2021: Best Lung Cancer IO Data

Pooled analysis supports chemo + immunotherapy for patients with PD-L1 1%-49%; immunosuppressants for adverse effects of immunotherapy; and AI predicts outcomes better than pathologic exam.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news